• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于胶朊酶及其有效抑制剂的联合分子建模研究。

A combined molecular modeling study on gelatinases and their potent inhibitors.

机构信息

Department of Chemistry, Lanzhou University, Lanzhou 730000, China.

出版信息

J Comput Chem. 2010 Jan 15;31(1):24-42. doi: 10.1002/jcc.21279.

DOI:10.1002/jcc.21279
PMID:19412908
Abstract

Zinc-dependent matrix metalloproteinase (MMP) family is considered to be an attractive target because of its important role in many physiological and pathological processes. In the present work, a molecular modeling study combining protein-, ligand- and complex-based computational methods was performed to analyze a new series of beta-N-biaryl ether sulfonamide hydroxamates as potent inhibitors of gelatinase A (MMP-2) and gelatinase B (MMP-9). Firstly, the similarities and differences between the binding sites of MMP-2 and MMP-9 were analyzed through sequence alignment and structural superimposition. Secondly, in order to extract structural features influencing the activities of these inhibitors, quantitative structure-activity relationship (QSAR) models using genetic algorithm-multiple linear regression (GA-MLR), comparative molecular field (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) were developed. The proposed QSAR models could give good predictive ability for the studied inhibitors. Thirdly, docking study was employed to further explore the binding mode between the ligand and protein. The results from all the above analyses could provide the information about the similarities and differences of the binding mode between the MMP-2, MMP-9 and their potent inhibitors. The obtained results can provide very useful information for the design of new potential inhibitors.

摘要

锌依赖的基质金属蛋白酶(MMP)家族因其在许多生理和病理过程中的重要作用而被认为是一个有吸引力的靶点。在本工作中,结合基于蛋白质、配体和复合物的计算方法进行了分子建模研究,以分析一系列新型β-N-双芳基醚磺酰胺羟肟酸作为明胶酶 A(MMP-2)和明胶酶 B(MMP-9)的有效抑制剂。首先,通过序列比对和结构叠加分析 MMP-2 和 MMP-9 结合位点的相似性和差异性。其次,为了提取影响这些抑制剂活性的结构特征,采用遗传算法-多元线性回归(GA-MLR)、比较分子场(CoMFA)和比较分子相似性指数分析(CoMSIA)等定量构效关系(QSAR)模型进行了定量构效关系(QSAR)研究。所提出的 QSAR 模型可以为研究抑制剂提供良好的预测能力。第三,采用对接研究进一步探讨配体与蛋白质的结合模式。通过以上所有分析得到的结果可以提供 MMP-2、MMP-9 及其有效抑制剂之间结合模式的相似性和差异性的信息。所得结果可为设计新的潜在抑制剂提供非常有用的信息。

相似文献

1
A combined molecular modeling study on gelatinases and their potent inhibitors.基于胶朊酶及其有效抑制剂的联合分子建模研究。
J Comput Chem. 2010 Jan 15;31(1):24-42. doi: 10.1002/jcc.21279.
2
beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.β-N-二芳基醚磺酰胺异羟肟酸酯作为有效的明胶酶抑制剂:第1部分。设计、合成及先导物鉴定。
Bioorg Med Chem Lett. 2008 Feb 1;18(3):1135-9. doi: 10.1016/j.bmcl.2007.11.119. Epub 2007 Dec 5.
3
beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.β-N-二芳基醚磺酰胺异羟肟酸酯作为有效的明胶酶抑制剂:第2部分。α-氨基取代基的优化。
Bioorg Med Chem Lett. 2008 Feb 1;18(3):1140-5. doi: 10.1016/j.bmcl.2007.11.129. Epub 2007 Dec 5.
4
QSAR analysis of some 5-amino-2-mercapto-1,3,4-thiadiazole based inhibitors of matrix metalloproteinases and bacterial collagenase.基于一些5-氨基-2-巯基-1,3,4-噻二唑的基质金属蛋白酶和细菌胶原酶抑制剂的定量构效关系分析
Bioorg Med Chem Lett. 2006 Jul 15;16(14):3847-54. doi: 10.1016/j.bmcl.2006.04.014. Epub 2006 May 8.
5
Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.依洛马司他P'1位同时存在不饱和键和长烷基链,分子模拟研究表明,这使其对明胶酶A(MMP - 2)的抑制作用比对明胶酶B(MMP - 9)的抑制作用更具选择性。
Bioorg Med Chem. 2007 Jul 15;15(14):4753-66. doi: 10.1016/j.bmc.2007.05.001. Epub 2007 May 6.
6
A novel series of highly selective inhibitors of MMP-3.一系列新型的基质金属蛋白酶-3高选择性抑制剂。
Bioorg Med Chem Lett. 2007 Dec 15;17(24):6750-3. doi: 10.1016/j.bmcl.2007.10.042. Epub 2007 Oct 17.
7
Sultam hydroxamates as novel matrix metalloproteinase inhibitors.磺酰胺异羟肟酸酯作为新型基质金属蛋白酶抑制剂。
J Med Chem. 2004 Jun 3;47(12):2981-3. doi: 10.1021/jm049833g.
8
QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.N-羟基-α-苯磺酰基乙酰胺衍生物对基质金属蛋白酶抑制作用的定量构效关系建模
Bioorg Med Chem. 2007 Sep 15;15(18):6298-310. doi: 10.1016/j.bmc.2007.06.014. Epub 2007 Jun 10.
9
Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (R)- and (S)-N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides.(R)-和(S)-N-羟基-2-(N-异丙氧基联苯-4-基磺酰胺基)-3-甲基丁酰胺的琥珀色力场实现、分子建模研究、合成及MMP-1/MMP-2抑制谱
Bioorg Med Chem. 2006 Jun 15;14(12):4260-76. doi: 10.1016/j.bmc.2006.01.056. Epub 2006 Feb 17.
10
Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.明胶酶催化结构域的同源性建模及新型磺胺类抑制剂的对接模拟
J Med Chem. 1999 May 20;42(10):1723-38. doi: 10.1021/jm980514x.